Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Enzo Life Sciences p53 activator (0.5mg)
Supplier: Enzo Life Sciences BMLP6030500
A peptide corresponding to 'peptide 46', (aa 361-382), which corresponds to the single-stranded DNA-end binding site of p53. This sequence is an activator of wild-type and certain p53 mutants. Fusion Peptide 46, a 35-mer peptide, consists of peptide 46 linked to a sequence from the third helix of Drosophila Antennapedia homeodomain protein in order to confer cell permeability. The p53 Activator (Fusion Peptide 46) has been demonstrated to have numerous effects including: rescue of p53 growth inhibition (5 µg/ml) in a human osteosarcoma Saos-2 subline transfected with His273 p53 mutant; at 20 µM, it induced 56% apoptosis in Burkitt lymphoma cell line Ew36 carrying wt p53; and it induced apoptosis in mutant p53 cell lines BL41 (20%) and SW480 (25%). It has no effect in p53 null cell lines HL60 and Saos-21. The p53 activator peptide is a useful tool to study p53. Alternative name: Fusion peptide 46. Purity: ≥97% (HPLC). Solubility: Soluble in Water. Long Term Storage: -20°C.
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?